Silviu Itescu
Fondatore presso MESOBLAST LIMITED
Patrimonio netto: 51 M $ in data 30/04/2024
Posizioni attive di Silviu Itescu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MESOBLAST LIMITED | Direttore/Membro del Consiglio | 01/01/2007 | - |
| Amministratore Delegato | 23/03/2011 | - | |
| Fondatore | 08/06/2004 | - | |
Mesoblast, Inc.
 Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Amministratore Delegato | 01/01/2004 | - |
| Fondatore | 01/01/2004 | - | |
| Columbia University Medical Center | Corporate Officer/Principal | 10/01/2011 | - |
Mesoblast UK Ltd.
 Mesoblast UK Ltd. Miscellaneous Commercial ServicesCommercial Services Mesoblast UK Ltd. engages in the provision of support services for the development of regenerative medicine products. The company was founded on April 7, 2011 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 07/04/2011 | - |
Storia della carriera di Silviu Itescu
Precedenti posizioni note di Silviu Itescu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| DIVERSA LIMITED | Direttore/Membro del Consiglio | - | 21/12/2006 |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | Corporate Officer/Principal | - | - |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | Corporate Officer/Principal | - | - |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
| Australia | 5 |
| Stati Uniti | 4 |
| Regno Unito | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
Settori
| Consumer Services | 5 |
| Health Technology | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MESOBLAST LIMITED | Health Technology |
| Aziende private | 3 |
|---|---|
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Health Technology |
Diversa Pty Ltd.
 Diversa Pty Ltd. Investment ManagersFinance Diversa Pty Ltd. engages in the provision of investment management and financial services. It operates through Superannuation Services and Trustee Services segments. The Superannuation Services segment provides administration and promotion services to superannuation funds and the issue of group risk products. The Trustee Services segment involves in the third party superannuation trustee services and investment services. The company was founded by Matthew Morgan and Angus Craig on July 03, 1997 and is headquartered in Melbourne, Australia. | Finance |
Mesoblast UK Ltd.
Mesoblast UK Ltd. Miscellaneous Commercial ServicesCommercial Services Mesoblast UK Ltd. engages in the provision of support services for the development of regenerative medicine products. The company was founded on April 7, 2011 and is headquartered in London, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Silviu Itescu
- Esperienza
